Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

717. Clinical trials, ethical dimensions, and the pathway of MDMA-assisted therapy in PTSD

Ethical concerns arise from MDMA’s affective and cognitive effects, which may influence vulnerability in the patient–therapist relationship, the emergence of memory and belief changes, and participants’ understanding of the intervention, as well as therapist's implicit and explicit therapy models.

C. Poppe, D. Repantis · 0 citations
Open access Aug 2026

Klassische Halluzinogene in der Behandlung von Suchterkrankungen – Ein narrativer Überblick

Zusammenfassung Klassische Halluzinogene („Psychedelika“) wie Lysergsäurediethylamid (LSD), Psilocybin, N,N-Dimethyltryptamin (DMT) und 5-Methoxydimethyltryptamin (5-MeO-DMT) werden zurzeit wieder als potenzielle Behandlungsoptionen bei Substanzgebrauchsstörungen untersucht. Psychedelika entfalten ihre Wirkung über ein...

Y. Kippe, C. Poppe, Dimitris Repantis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.